Covered recipient · General Payments record
BAILLIE STEELE
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2023–2024
$1,326.63
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $756.28 | 24 |
| Education | $188.95 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $223.26 | 2 |
| Amgen Inc. | $207.76 | 7 |
| Incyte Corporation | $187.54 | 4 |
| SANOFI-AVENTIS U.S. LLC | $89.95 | 1 |
| GENZYME CORPORATION | $76.61 | 4 |
| Lilly USA, LLC | $65.03 | 3 |
| UCB, Inc. | $37.38 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $26.96 | 1 |
| ABBVIE INC. | $16.87 | 1 |
| Dermavant Sciences, Inc. | $13.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.87 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108248471 | CMS |
| Amgen Inc. | $32.62 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117692218 | CMS |
| Amgen Inc. | $11.21 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117692220 | CMS |
| Amgen Inc. | $26.02 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117692222 | CMS |
| Amgen Inc. | $8.46 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117692224 | CMS |
| Amgen Inc. | $15.95 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117692226 | CMS |
| Amgen Inc. | $88.92 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117692230 | CMS |
| Amgen Inc. | $24.58 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117692228 | CMS |
| Dermavant Sciences, Inc. | $13.87 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128016254 | CMS |
| GENZYME CORPORATION | $13.71 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139842493 | CMS |
| GENZYME CORPORATION | $18.60 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139842501 | CMS |
| GENZYME CORPORATION | $16.44 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139842507 | CMS |
| GENZYME CORPORATION | $27.86 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139842517 | CMS |
| Incyte Corporation | $13.44 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141196715 | CMS |
| Incyte Corporation | $19.51 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141249532 | CMS |
| Incyte Corporation | $126.68 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141191057 | CMS |
| Incyte Corporation | $27.91 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141201577 | CMS |
| Janssen Biotech, Inc. | $124.26 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078628475 | CMS |
| Janssen Biotech, Inc. | $99.00 | 06/24/2024 | Education | Undisputed | 01/23/2026 | 1078628648 | CMS |
| Lilly USA, LLC | $19.74 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135540461 | CMS |
| Lilly USA, LLC | $21.53 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135540465 | CMS |
| Lilly USA, LLC | $23.76 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135561414 | CMS |
| Novartis Pharmaceuticals Corporation | $26.96 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087317159 | CMS |
| SANOFI-AVENTIS U.S. LLC | $89.95 | 08/01/2024 | Education | Undisputed | 01/23/2026 | 1139842461 | CMS |
| UCB, Inc. | $16.38 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143242279 | CMS |
| UCB, Inc. | $21.00 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143242284 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.